State Street Corp Kezar Life Sciences, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, State Street Corp holds 185,941 shares of KZR stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

185,941

Previous 185,941 -0.0%

Holding current value

$1.39 Million

Previous $111,000 28.83%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.6 - $0.92 $562,699 - $862,806	-937,833 Reduced 83.45%	185,941 $111,000
Q1 2024 May 15, 2024	BUY	$0.8 - $1.05 $6,177 - $8,108	7,722 Added 0.69%	1,123,774 $1.01 Million
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.15 $2,514 - $4,015	3,492 Added 0.31%	1,116,052 $1.06 Million
Q3 2023 Nov 14, 2023	BUY	$1.08 - $2.54 $18,191 - $42,783	16,844 Added 1.54%	1,112,560 $1.32 Million
Q2 2023 Aug 14, 2023	SELL	$2.31 - $3.06 $4.95 Million - $6.56 Million	-2,143,717 Reduced 66.18%	1,095,716 $2.68 Million
Q1 2023 May 15, 2023	SELL	$3.13 - $7.31 $3.18 Million - $7.42 Million	-1,014,527 Reduced 23.85%	3,239,433 $10.1 Million
Q4 2022 Feb 14, 2023	BUY	$6.39 - $8.8 $4.58 Million - $6.3 Million	716,259 Added 20.25%	4,253,960 $29.9 Million
Q3 2022 Nov 15, 2022	BUY	$7.99 - $10.75 $22.4 Million - $30.1 Million	2,802,611 Added 381.26%	3,537,701 $30.5 Million
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $6.9 Million - $25.8 Million	-1,507,464 Reduced 67.22%	735,090 $6.08 Million
Q1 2022 May 16, 2022	BUY	$12.3 - $18.33 $11.1 Million - $16.5 Million	902,588 Added 67.36%	2,242,554 $37.3 Million
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $5.47 Million - $12.3 Million	734,562 Added 121.33%	1,339,966 $22.4 Million
Q3 2021 Nov 15, 2021	BUY	$4.85 - $9.73 $439,477 - $881,674	90,614 Added 17.6%	605,404 $5.23 Million
Q2 2021 Aug 16, 2021	BUY	$4.93 - $6.46 $215,189 - $281,972	43,649 Added 9.26%	514,790 $2.8 Million
Q1 2021 May 17, 2021	SELL	$5.24 - $6.99 $172,741 - $230,432	-32,966 Reduced 6.54%	471,141 $2.81 Million
Q4 2020 Feb 16, 2021	SELL	$4.77 - $6.58 $12,592 - $17,371	-2,640 Reduced 0.52%	504,107 $2.63 Million
Q3 2020 Nov 10, 2020	SELL	$4.36 - $5.5 $28,706 - $36,212	-6,584 Reduced 1.28%	506,747 $2.45 Million
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.75 $307,551 - $662,090	85,431 Added 19.97%	513,331 $2.66 Million
Q1 2020 May 11, 2020	BUY	$2.77 - $5.75 $1.19 Million - $2.46 Million	427,900 New	427,900 $1.87 Million

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $512M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Kezar Life Sciences, Inc. Transaction History